Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.52 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.28.
Market Cap
8.52T
Revenue
4.59T
Profits
201.46B
PE Ratio
42.28
Profit Margin
4.39%
Dividend Yield
0.42%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.39% | 3,820,720 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 570.51B | 2.08% | 8,351,218 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 398.27B | 1.05% | 4,257,627 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 375.06B | 1.58% | 8,590,328 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 295.39B | 0.07% | 9,668,872 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 283.03B | 1.04% | 1,963,233 | 60.44B |
| 7 | NVS | Novartis AG | 271.88B | 1.84% | 2,418,843 | 56.58B |
| 8 | AMGN | Amgen Inc. | 185.96B | -0.34% | 3,388,240 | 37.22B |
| 9 | NVO | Novo Nordisk A/S | 184.75B | 2.85% | 14,720,102 | 50.57B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 183.61B | 5.20% | 2,791,169 | 45.20B |
| 11 | ABT | Abbott Laboratories | 158.94B | 0.83% | 14,109,082 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 155.82B | -2.03% | 8,682,712 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 151.09B | 1.91% | 2,275,316 | 10.58B |
| 14 | PFE | Pfizer Inc. | 146.48B | 0.31% | 35,273,018 | 63.32B |
| 15 | DHR | Danaher Corporation | 133.35B | 2.66% | 5,872,187 | 24.78B |
| 16 | CVS | CVS Health Corporation | 123.84B | -0.02% | 6,175,777 | 405.62B |
| 17 | SYK | Stryker Corporation | 120.38B | 4.14% | 2,701,757 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 115.34B | 1.64% | 11,952,641 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.14B | 0.63% | 871,093 | 12.22B |
| 20 | SNY | Sanofi | 106.90B | 1.94% | 2,832,066 | 54.60B |
| 21 | MDT | Medtronic plc | 105.25B | 1.60% | 9,825,462 | 36.36B |
| 22 | GSK | GSK plc | 101.72B | 1.20% | 6,115,441 | 43.29B |
| 23 | MCK | McKesson Corporation | 94.27B | 2.29% | 882,348 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 92.17B | 1.50% | 1,767,608 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.17B | 3.76% | 1,663,392 | 76.39B |
| 26 | CI | The Cigna Group | 78.04B | 1.86% | 1,685,614 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.77B | 0.53% | 18,196,081 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.69B | 0.79% | 1,190,399 | 14.92B |
| 29 | ARGX | argenx SE | 54.50B | 0.18% | 304,712 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.39B | 2.00% | 1,282,218 | 328.68B |
| 31 | EW | Edwards Lifesciences Corporation | 50.41B | 1.97% | 3,442,463 | 6.30B |
| 32 | CAH | Cardinal Health, Inc. | 49.81B | 4.01% | 3,190,387 | 250.74B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.04B | -0.13% | 4,585,570 | 28.34B |
| 34 | MDLN | Medline Inc. | 47.31B | 6.54% | 10,167,567 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.66B | 3.16% | 452,308 | 4.45B |
| 36 | HUM | Humana Inc. | 43.60B | 2.02% | 1,436,171 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 41.89B | 2.08% | 2,214,275 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 40.11B | 3.58% | 6,366,845 | 17.35B |
| 39 | HLN | Haleon plc | 39.79B | 2.59% | 9,333,044 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.75B | 1.89% | 1,259,816 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 38.26B | 2.10% | 2,308,346 | 7.23B |
| 42 | WAT | Waters Corporation | 36.44B | 2.15% | 860,022 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 34.46B | 4.29% | 6,991,180 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.86B | 2.71% | 1,469,598 | 10.63B |
| 45 | CNC | Centene Corporation | 32.69B | 1.81% | 5,435,330 | 178.33B |
| 46 | RPRX | Royalty Pharma plc | 32.03B | 1.40% | 3,746,778 | 2.44B |
| 47 | NTRA | Natera, Inc. | 31.91B | 4.38% | 1,210,479 | 2.50B |
| 48 | RVMD | Revolution Medicines, Inc. | 31.79B | 0.71% | 2,766,460 | - |
| 49 | IQV | IQVIA Holdings Inc. | 31.09B | 1.39% | 1,311,163 | 16.63B |
| 50 | DXCM | DexCom, Inc. | 30.17B | 2.05% | 5,424,007 | 4.82B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 30.03B | 2.07% | 4,875,062 | 20.98B |
| 52 | ONC | BeOne Medicines AG | 29.81B | -0.97% | 515,453 | 5.70B |
| 53 | BIIB | Biogen Inc. | 29.39B | 3.36% | 937,793 | 9.94B |
| 54 | RMD | ResMed Inc. | 28.44B | 1.97% | 1,024,091 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 27.24B | 0.26% | 2,313,488 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 25.07B | 2.63% | 1,637,372 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.21B | 1.26% | 1,455,057 | 4.39B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.64B | 4.66% | 649,952 | 3.22B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.50B | 2.10% | 312,000 | 4.09B |
| 60 | UTHR | United Therapeutics Corporation | 23.48B | 1.55% | 340,440 | 3.17B |
| 61 | DGX | Quest Diagnostics Incorporated | 22.64B | 3.71% | 747,133 | 11.28B |
| 62 | LH | Labcorp Holdings Inc. | 22.24B | 3.52% | 602,373 | 14.14B |
| 63 | BNTX | BioNTech SE | 21.87B | 1.17% | 1,173,252 | 3.23B |
| 64 | INSM | Insmed Incorporated | 21.47B | 5.17% | 4,240,876 | 819.56M |
| 65 | ROIV | Roivant Sciences Ltd. | 20.89B | 1.97% | 3,486,635 | 8.26M |
| 66 | STE | STERIS plc | 20.78B | 1.36% | 858,722 | 5.94B |
| 67 | INCY | Incyte Corporation | 20.62B | 2.57% | 2,318,919 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.94B | 0.27% | 5,080,448 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.87B | 1.69% | 8,286,107 | 14.56B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 17.34B | 2.70% | 1,869,778 | 8.41B |
| 71 | GH | Guardant Health, Inc. | 17.25B | 4.19% | 2,258,165 | 1.08B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.61B | 1.30% | 1,098,906 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.29B | 1.21% | 1,329,445 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.38B | -1.23% | 727,833 | 4.44B |
| 75 | THC | Tenet Healthcare Corporation | 14.33B | 2.06% | 1,245,732 | 21.46B |
| 76 | SOLV | Solventum Corporation | 14.28B | 4.70% | 1,813,710 | 8.26B |
| 77 | COO | The Cooper Companies, Inc. | 13.38B | 2.74% | 4,484,302 | 4.23B |
| 78 | MEDP | Medpace Holdings, Inc. | 13.33B | 1.94% | 284,277 | 2.68B |
| 79 | EXEL | Exelixis, Inc. | 13.32B | 2.42% | 1,774,297 | 2.38B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 13.26B | 0.46% | 1,836,953 | 579.96M |
| 81 | ASND | Ascendis Pharma A/S | 13.24B | 3.61% | 540,524 | 998.25M |
| 82 | SNN | Smith & Nephew plc | 13.10B | 3.23% | 1,408,268 | 6.16B |
| 83 | ALGN | Align Technology, Inc. | 12.76B | 3.52% | 1,039,529 | 4.10B |
| 84 | DVA | DaVita Inc. | 12.72B | 3.18% | 679,853 | 13.84B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 12.71B | 3.01% | 5,538,728 | 13.65B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.64B | 4.47% | 917,883 | 708.24M |
| 87 | PEN | Penumbra, Inc. | 12.63B | 0.31% | 441,271 | 1.45B |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 12.33B | 1.41% | 1,568,662 | 1.06B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.24B | 3.46% | 5,130,819 | 4.89B |
| 90 | FMS | Fresenius Medical Care AG | 11.99B | 2.57% | 559,921 | 22.32B |
| 91 | ICLR | ICON Public Limited Company | 11.62B | -0.28% | 1,220,450 | 8.25B |
| 92 | RVTY | Revvity, Inc. | 11.62B | 3.82% | 1,243,114 | 2.90B |
| 93 | GMED | Globus Medical, Inc. | 11.20B | 5.39% | 1,482,634 | 3.10B |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.19B | 2.40% | 2,767,317 | 3.24B |
| 95 | SMMT | Summit Therapeutics Inc. | 11.09B | 1.28% | 5,034,903 | - |
| 96 | RDY | Dr. Reddy's Laboratories Limited | 11.08B | 1.06% | 1,675,824 | 3.58B |
| 97 | PODD | Insulet Corporation | 11.06B | 5.35% | 1,820,100 | 2.90B |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.00B | 2.06% | 285,806 | 1.13B |
| 99 | MOH | Molina Healthcare, Inc. | 10.58B | 2.34% | 1,228,548 | 43.10B |
| 100 | BAX | Baxter International Inc. | 10.34B | 4.11% | 6,492,795 | 11.32B |
| 101 | EHC | Encompass Health Corporation | 10.34B | 3.05% | 781,954 | 6.07B |
| 102 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.33B | -0.72% | 1,415,234 | 622.01M |
| 103 | RGC | Regencell Bioscience Holdings Limited | 10.06B | -5.05% | 94,111 | - |
| 104 | NUVL | Nuvalent, Inc. | 9.74B | 39.28% | 51,699,503 | - |
| 105 | MASI | Masimo Corporation | 9.42B | 0.01% | 3,160,088 | 1.56B |
| 106 | CYTK | Cytokinetics, Incorporated | 9.29B | 0.81% | 2,492,667 | 105.82M |
| 107 | CRL | Charles River Laboratories International, Inc. | 9.14B | 1.83% | 777,575 | 4.03B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.13B | 2.65% | 233,122 | 417.30M |
| 109 | HSIC | Henry Schein, Inc. | 9.12B | 2.54% | 2,259,328 | 13.38B |
| 110 | ENSG | The Ensign Group, Inc. | 9.00B | -0.75% | 1,147,538 | 5.27B |
| 111 | UHS | Universal Health Services, Inc. | 8.87B | 2.60% | 1,062,512 | 17.76B |
| 112 | TEM | Tempus AI, Inc. | 8.77B | 0.47% | 7,351,277 | 1.36B |
| 113 | BRKR | Bruker Corporation | 8.71B | 1.74% | 2,248,680 | 3.46B |
| 114 | TECH | Bio-Techne Corporation | 8.52B | 3.34% | 3,553,741 | 1.21B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.48B | 1.06% | 1,317,198 | 1.51B |
| 116 | CORT | Corcept Therapeutics Incorporated | 8.32B | 5.67% | 1,010,542 | 769.10M |
| 117 | OSCR | Oscar Health, Inc. | 8.20B | -0.62% | 9,131,997 | 13.30B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.95B | 2.01% | 436,938 | 2.59B |
| 119 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 7.90B | 1.17% | 1,182,905 | 5.67M |
| 120 | QGEN | Qiagen N.V. | 7.81B | 4.20% | 2,159,380 | 2.10B |
| 121 | IBRX | ImmunityBio, Inc. | 7.59B | 1.12% | 12,672,982 | 140.98M |
| 122 | HQY | HealthEquity, Inc. | 7.46B | 1.58% | 803,727 | 1.34B |
| 123 | GKOS | Glaukos Corporation | 7.42B | 3.59% | 1,082,314 | 551.35M |
| 124 | ATR | AptarGroup, Inc. | 7.40B | 3.54% | 444,301 | 3.87B |
| 125 | ALKS | Alkermes plc | 7.38B | 4.33% | 2,519,515 | 1.56B |
| 126 | RGEN | Repligen Corporation | 7.34B | 3.83% | 1,466,717 | 763.34M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 6.98B | -1.15% | 465,491 | 7.46M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.81B | 8.00% | 878,565 | 74.06M |
| 129 | PCVX | Vaxcyte, Inc. | 6.77B | 1.19% | 1,318,816 | - |
| 130 | AVTR | Avantor, Inc. | 6.77B | 2.27% | 14,077,373 | 6.55B |
| 131 | HIMS | Hims & Hers Health, Inc. | 6.71B | 6.66% | 25,444,667 | 2.37B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.64B | 6.17% | 1,592,938 | - |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.03% | 659,424 | 1.55B |
| 134 | IMVT | Immunovant, Inc. | 6.49B | 2.63% | 1,699,785 | - |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.37B | 2.42% | 643,804 | - |
| 136 | KYMR | Kymera Therapeutics, Inc. | 6.33B | 4.00% | 748,279 | 51.48M |
| 137 | GRFS | Grifols, S.A. | 6.29B | 0.14% | 737,350 | 8.58B |
| 138 | LEGN | Legend Biotech Corporation | 6.22B | 6.25% | 2,578,911 | 1.14B |
| 139 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.15% | 2,302,698 | 15.00M |
| 140 | TGTX | TG Therapeutics, Inc. | 6.15B | 5.91% | 2,587,686 | 700.35M |
| 141 | PTCT | PTC Therapeutics, Inc. | 6.11B | 3.97% | 1,873,808 | 827.11M |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | 2.25% | 626,164 | 217.17M |
| 143 | TFX | Teleflex Incorporated | 6.01B | 3.04% | 579,532 | 2.13B |
| 144 | CHE | Chemed Corporation | 5.90B | 1.62% | 161,292 | 2.54B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | 2.02% | 694,228 | 569.61M |
| 146 | LQDA | Liquidia Corporation | 5.69B | 0.17% | 1,624,120 | 288.07M |
| 147 | BLCO | Bausch + Lomb Corporation | 5.58B | 3.10% | 473,982 | 5.21B |
| 148 | PACS | PACS Group, Inc. | 5.57B | 0.37% | 709,280 | 5.43B |
| 149 | BLTE | Belite Bio, Inc | 5.56B | 1.28% | 203,234 | - |
| 150 | COGT | Cogent Biosciences, Inc. | 5.47B | 2.63% | 3,082,220 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.46B | 4.06% | 978,811 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.10B | 3.24% | 1,429,827 | 7.50M |
| 153 | CGON | CG Oncology, Inc. | 5.00B | 4.25% | 1,236,655 | 5.07M |
| 154 | CRSP | CRISPR Therapeutics AG | 4.97B | -0.23% | 1,461,779 | 4.10M |
| 155 | STVN | Stevanato Group S.p.A. | 4.94B | 0.56% | 484,567 | 1.39B |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 4.88B | 2.33% | 173,528 | 274.48M |
| 157 | HNGE | Hinge Health, Inc. | 4.86B | -0.13% | 1,866,861 | 646.34M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.79B | 5.08% | 3,534,150 | 907.29M |
| 159 | SHC | Sotera Health Company | 4.71B | 4.22% | 3,661,206 | 1.19B |
| 160 | BLLN | BillionToOne, Inc. | 4.71B | 8.43% | 676,880 | 354.54M |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 4.69B | 7.15% | 2,424,105 | 3.05B |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 4.62B | 4.12% | 954,686 | 1.34M |
| 163 | TNGX | Tango Therapeutics, Inc. | 4.57B | 2.04% | 7,198,158 | 56.99M |
| 164 | TVTX | Travere Therapeutics, Inc. | 4.52B | 3.16% | 2,621,918 | 536.20M |
| 165 | CELC | Celcuity Inc. | 4.52B | 5.90% | 1,374,398 | - |
| 166 | RDNT | RadNet, Inc. | 4.42B | 3.73% | 657,135 | 2.14B |
| 167 | TWST | Twist Bioscience Corporation | 4.36B | 0.03% | 1,797,100 | 409.48M |
| 168 | MMED | MiniMed Group, Inc. | 4.25B | 1.61% | 798,904 | 3.10B |
| 169 | LIVN | LivaNova PLC | 4.24B | 3.17% | 673,998 | 1.43B |
| 170 | ERAS | Erasca, Inc. | 4.17B | 4.20% | 4,650,851 | - |
| 171 | ORKA | Oruka Therapeutics, Inc. | 4.04B | 4.48% | 1,566,517 | - |
| 172 | MMSI | Merit Medical Systems, Inc. | 4.03B | 2.24% | 940,501 | 1.54B |
| 173 | MANE | Veradermics, Incorporated | 4.01B | 6.19% | 494,338 | - |
| 174 | NVST | Envista Holdings Corporation | 4.00B | 4.91% | 2,877,812 | 2.81B |
| 175 | ALHC | Alignment Healthcare, Inc. | 3.97B | 25.08% | 16,332,304 | 4.26B |
| 176 | VCYT | Veracyte, Inc. | 3.93B | 4.17% | 1,009,554 | 541.74M |
| 177 | TXG | 10x Genomics, Inc. | 3.88B | 4.83% | 3,285,829 | 638.78M |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.19% | 1,350,156 | 596.96M |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.75B | -0.69% | 522,384 | 754.05M |
| 180 | IRTC | iRhythm Holdings, Inc. | 3.74B | 6.15% | 583,404 | 787.85M |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | 0.65% | 1,104,650 | 1.10B |
| 182 | DOCS | Doximity, Inc. | 3.74B | 0.74% | 4,101,224 | 644.86M |
| 183 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.69B | 4.45% | 884,725 | 18.07M |
| 184 | WAY | Waystar Holding Corp. | 3.68B | 1.00% | 1,879,677 | 1.16B |
| 185 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | -2.24% | 1,354,133 | - |
| 186 | HAE | Haemonetics Corporation | 3.58B | 5.11% | 1,888,091 | 1.33B |
| 187 | ICUI | ICU Medical, Inc. | 3.55B | 3.42% | 274,599 | 2.16B |
| 188 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | -1.84% | 1,114,351 | 22.57M |
| 189 | OGN | Organon & Co. | 3.52B | 0.07% | 1,781,319 | 6.16B |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.39B | -0.03% | 2,252,098 | - |
| 191 | CON | Concentra Group Holdings Parent, Inc. | 3.34B | 2.55% | 1,019,886 | 2.23B |
| 192 | OPCH | Option Care Health, Inc. | 3.31B | 5.13% | 3,984,102 | 5.67B |
| 193 | DNLI | Denali Therapeutics Inc. | 3.30B | 6.40% | 1,916,842 | - |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.20B | 2.06% | 107,935 | 803.79M |
| 195 | ITGR | Integer Holdings Corporation | 3.20B | 2.41% | 435,152 | 1.86B |
| 196 | RLAY | Relay Therapeutics, Inc. | 3.07B | 3.15% | 2,963,903 | 10.68M |
| 197 | BKD | Brookdale Senior Living Inc. | 3.07B | 8.34% | 6,483,131 | 3.00B |
| 198 | WRBY | Warby Parker Inc. | 3.05B | 5.57% | 4,310,618 | 890.57M |
| 199 | BEAM | Beam Therapeutics Inc. | 3.03B | 2.32% | 1,571,804 | 164.01M |
| 200 | NHC | National HealthCare Corporation | 3.00B | 2.34% | 142,535 | 1.53B |
| 201 | RCUS | Arcus Biosciences, Inc. | 2.97B | 1.37% | 1,160,527 | 236.00M |
| 202 | LFST | LifeStance Health Group, Inc. | 2.97B | 4.36% | 1,936,416 | 1.49B |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.96B | 6.60% | 1,701,206 | - |
| 204 | GPCR | Structure Therapeutics Inc. | 2.93B | 9.21% | 1,873,127 | - |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 2.85B | 5.80% | 1,777,409 | 415.62M |
| 206 | PRVA | Privia Health Group, Inc. | 2.79B | 3.55% | 1,438,898 | 2.25B |
| 207 | ADPT | Adaptive Biotechnologies Corporation | 2.78B | 3.95% | 2,216,573 | 295.41M |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.65B | 2.65% | 380,767 | 776.83M |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | 3.26% | 308,399 | 1.46B |
| 210 | TARS | Tarsus Pharmaceuticals, Inc. | 2.65B | 3.20% | 615,559 | 535.08M |
| 211 | GRAL | GRAIL, Inc. | 2.61B | -1.01% | 556,498 | 156.12M |
| 212 | IRON | Disc Medicine, Inc. | 2.61B | 3.86% | 590,177 | - |
| 213 | TMDX | TransMedics Group, Inc. | 2.57B | 4.43% | 1,254,376 | 635.89M |
| 214 | ALMS | Alumis Inc. | 2.55B | 5.37% | 1,414,873 | 8.40M |
| 215 | KLRA | Kailera Therapeutics, Inc. | 2.54B | -0.30% | 577,121 | - |
| 216 | DFTX | Definium Therapeutics, Inc. | 2.50B | -0.30% | 1,969,688 | - |
| 217 | HTFL | HeartFlow, Inc. | 2.47B | 0.77% | 652,888 | 191.42M |
| 218 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -10.83% | 4,244,076 | 225.27M |
| 219 | ESTA | Establishment Labs Holdings Inc. | 2.35B | 6.65% | 880,899 | 229.58M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.35B | 0.71% | 2,725,955 | 3.37B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.32B | 3.64% | 616,942 | 865.00K |
| 222 | PBH | Prestige Consumer Healthcare Inc. | 2.31B | 1.97% | 772,651 | 1.09B |
| 223 | VERA | Vera Therapeutics, Inc. | 2.28B | 0.19% | 913,363 | - |
| 224 | AXGN | Axogen, Inc. | 2.28B | 3.40% | 1,138,900 | 238.11M |
| 225 | CLOV | Clover Health Investments, Corp. | 2.26B | 9.44% | 15,054,216 | 2.21B |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | 5.56% | 1,622,570 | 670.00M |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.21B | 1.56% | 444,792 | 256.28M |
| 228 | PHVS | Pharvaris N.V. | 2.20B | 0.03% | 465,868 | - |
| 229 | ELVN | Enliven Therapeutics, Inc. | 2.20B | 7.37% | 1,834,737 | - |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.12B | -1.19% | 3,797,872 | 885.72M |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.10B | 2.05% | 5,499,719 | 3.68B |
| 232 | IMNM | Immunome, Inc. | 2.08B | -1.18% | 1,077,310 | 4.02M |
| 233 | SEM | Select Medical Holdings Corporation | 2.06B | 0.36% | 1,418,722 | 5.52B |
| 234 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | 0.77% | 982,511 | 298.30M |
| 235 | PGNY | Progyny, Inc. | 2.02B | -0.35% | 1,588,279 | 1.29B |
| 236 | NEOG | Neogen Corporation | 2.02B | 2.43% | 1,814,642 | 870.56M |
| 237 | NVCR | NovoCure Limited | 2.00B | 2.31% | 1,544,027 | 674.41M |
| 238 | MLYS | Mineralys Therapeutics, Inc. | 1.99B | 7.47% | 2,550,449 | - |
| 239 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | 5.28% | 1,091,497 | 899.11M |
| 240 | HCM | HUTCHMED (China) Limited | 1.96B | -2.03% | 54,138 | 548.51M |
| 241 | KOD | Kodiak Sciences Inc. | 1.94B | 4.90% | 705,076 | - |
| 242 | BHC | Bausch Health Companies Inc. | 1.93B | 1.17% | 1,807,485 | 10.53B |
| 243 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 0.63% | 1,318,599 | - |
| 244 | NKTR | Nektar Therapeutics | 1.90B | -0.69% | 1,173,331 | 55.63M |
| 245 | ASTH | Astrana Health, Inc. | 1.90B | -0.26% | 474,932 | 3.53B |
| 246 | MD | Pediatrix Medical Group, Inc. | 1.90B | 5.30% | 745,573 | 1.93B |
| 247 | VCEL | Vericel Corporation | 1.89B | 3.27% | 628,276 | 292.09M |
| 248 | ADMA | ADMA Biologics, Inc. | 1.88B | 0.74% | 3,115,842 | 509.86M |
| 249 | ZLAB | Zai Lab Limited | 1.87B | 1.03% | 1,373,404 | 453.28M |
| 250 | MESO | Mesoblast Limited | 1.86B | 3.48% | 173,709 | 65.38M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 1.85B | 3.80% | 2,426,937 | 52.04M |
| 252 | OMCL | Omnicell, Inc. | 1.85B | -3.00% | 692,072 | 1.23B |
| 253 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 1.58% | 191,921 | 1.20B |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.83B | 1.28% | 453,564 | 32.08M |
| 255 | SGRY | Surgery Partners, Inc. | 1.81B | 0.72% | 828,078 | 3.34B |
| 256 | VRDN | Viridian Therapeutics, Inc. | 1.80B | 3.69% | 1,174,918 | 70.92M |
| 257 | NTLA | Intellia Therapeutics, Inc. | 1.80B | -4.45% | 5,627,600 | 66.09M |
| 258 | PLSE | Pulse Biosciences, Inc. | 1.79B | 4.05% | 218,633 | 751.00K |
| 259 | UFPT | UFP Technologies, Inc. | 1.79B | 1.95% | 257,123 | 608.85M |
| 260 | IOVA | Iovance Biotherapeutics, Inc. | 1.73B | -3.00% | 11,270,614 | 285.61M |
| 261 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | 1.34% | 271,942 | 923.71M |
| 262 | NUVB | Nuvation Bio Inc. | 1.72B | 2.71% | 9,714,459 | 143.05M |
| 263 | RAPP | Rapport Therapeutics, Inc. | 1.71B | -2.29% | 256,680 | 20.00M |
| 264 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -3.01% | 17,847,932 | 66.41M |
| 265 | AGL | agilon health, inc. | 1.70B | 7.16% | 235,021 | 5.82B |
| 266 | ZYME | Zymeworks Inc. | 1.70B | -2.80% | 875,735 | 81.26M |
| 267 | ADUS | Addus HomeCare Corporation | 1.69B | 2.19% | 152,138 | 1.45B |
| 268 | GENB | Generate Biomedicines, Inc. | 1.69B | 3.21% | 615,476 | 30.30M |
| 269 | NBTX | Nanobiotix S.A. | 1.69B | -4.29% | 109,569 | 38.27M |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 2.19% | 2,437,071 | 2.18B |
| 271 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | 2.79% | 1,290,568 | 66.05M |
| 272 | WGS | GeneDx Holdings Corp. | 1.67B | 8.75% | 1,389,887 | 442.68M |
| 273 | BHVN | Biohaven Ltd. | 1.67B | -0.27% | 3,772,644 | - |
| 274 | QURE | uniQure N.V. | 1.67B | -2.00% | 1,182,637 | 18.09M |
| 275 | SNDA | Sonida Senior Living, Inc. | 1.66B | 6.48% | 590,261 | 367.34M |
| 276 | INVA | Innoviva, Inc. | 1.66B | 0.94% | 738,501 | 420.69M |
| 277 | PRCT | PROCEPT BioRobotics Corporation | 1.64B | 1.52% | 1,292,411 | 322.02M |
| 278 | ABCL | AbCellera Biologics Inc. | 1.62B | -2.21% | 5,672,301 | 79.21M |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.62B | - | 6,665,202 | 71.78M |
| 280 | FTRE | Fortrea Holdings Inc. | 1.60B | 1.87% | 867,238 | 2.71B |
| 281 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | 4.30% | 1,435,471 | 217.17M |
| 282 | AAPG | Ascentage Pharma Group International | 1.56B | -0.29% | 2,569 | 82.08M |
| 283 | PRGO | Perrigo Company plc | 1.55B | -3.70% | 5,207,328 | 4.18B |
| 284 | TYRA | Tyra Biosciences, Inc. | 1.54B | -3.03% | 1,424,038 | - |
| 285 | TSHA | Taysha Gene Therapies, Inc. | 1.54B | -1.29% | 4,310,598 | 7.47M |
| 286 | SION | Sionna Therapeutics, Inc. | 1.52B | 0.54% | 320,199 | - |
| 287 | CMPS | COMPASS Pathways plc | 1.52B | -4.01% | 3,545,338 | - |
| 288 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.51B | 4.15% | 999,019 | -665.00K |
| 289 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -0.57% | 976,366 | 11.13M |
| 290 | ANAB | AnaptysBio, Inc. | 1.50B | 0.53% | 452,607 | 232.39M |
| 291 | PVLA | Palvella Therapeutics, Inc. | 1.50B | -0.84% | 362,291 | - |
| 292 | AVAH | Aveanna Healthcare Holdings Inc. | 1.50B | 3.46% | 1,673,482 | 2.52B |
| 293 | NEO | NeoGenomics, Inc. | 1.49B | 4.47% | 1,979,047 | 745.97M |
| 294 | STAA | STAAR Surgical Company | 1.49B | -0.30% | 598,844 | 290.38M |
| 295 | HCSG | Healthcare Services Group, Inc. | 1.46B | 3.80% | 529,936 | 1.85B |
| 296 | IMCR | Immunocore Holdings plc | 1.45B | 2.66% | 319,569 | 412.81M |
| 297 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | - | 1,537,918 | 114.48M |
| 298 | VIR | Vir Biotechnology, Inc. | 1.44B | 0.71% | 1,657,914 | 65.50M |
| 299 | SLS | SELLAS Life Sciences Group, Inc. | 1.43B | -3.76% | 6,924,794 | - |
| 300 | ATAI | AtaiBeckley Inc. | 1.43B | 2.10% | 5,405,296 | 3.49M |
| 301 | NVAX | Novavax, Inc. | 1.43B | 0.58% | 4,589,831 | 596.34M |
| 302 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 0.16% | 360,102 | - |
| 303 | MBX | MBX Biosciences, Inc. | 1.42B | 3.00% | 324,316 | - |
| 304 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -2.29% | 832,821 | 42.95M |
| 305 | SEPN | Septerna, Inc. | 1.40B | 1.97% | 277,830 | 72.26M |
| 306 | GHRS | GH Research PLC | 1.40B | 1.14% | 270,661 | - |
| 307 | ALMR | Alamar Biosciences, Inc. | 1.40B | 4.79% | 138,073 | 87.16M |
| 308 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 5.67% | 1,092,392 | 1.64B |
| 309 | ARDX | Ardelyx, Inc. | 1.38B | 1.08% | 2,977,932 | 427.68M |
| 310 | ATRC | AtriCure, Inc. | 1.38B | 1.41% | 607,249 | 552.16M |
| 311 | ENOV | Enovis Corporation | 1.38B | 1.18% | 979,245 | 2.28B |
| 312 | URGN | UroGen Pharma Ltd. | 1.37B | 3.41% | 830,889 | 140.49M |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.35B | 2.29% | 619,084 | - |
| 314 | ARDT | Ardent Health, Inc. | 1.35B | 6.57% | 556,301 | 6.43B |
| 315 | BLFS | BioLife Solutions, Inc. | 1.35B | 5.56% | 712,812 | 101.66M |
| 316 | BFLY | Butterfly Network, Inc. | 1.34B | 7.11% | 5,427,087 | 102.92M |
| 317 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -0.64% | 251,905 | - |
| 318 | PAHC | Phibro Animal Health Corporation | 1.32B | 2.80% | 208,009 | 1.50B |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.32B | 1.48% | 679,457 | 20.00M |
| 320 | PGEN | Precigen, Inc. | 1.32B | 3.92% | 3,545,656 | 31.60M |
| 321 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.32B | 1.19% | 3,115,540 | 204.73M |
| 322 | MLTX | MoonLake Immunotherapeutics | 1.31B | -1.11% | 962,577 | - |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.31B | -0.03% | 248,144 | 1.30M |
| 324 | AHCO | AdaptHealth Corp. | 1.31B | 1.66% | 895,330 | 3.29B |
| 325 | ALVO | Alvotech | 1.30B | -1.89% | 1,431,173 | 562.04M |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.29B | -0.12% | 462,125 | - |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.27B | 4.42% | 2,728,998 | 787.08M |
| 328 | TDOC | Teladoc Health, Inc. | 1.25B | -2.12% | 3,529,692 | 2.51B |
| 329 | SVRA | Savara Inc. | 1.25B | -2.57% | 3,133,233 | - |
| 330 | HROW | Harrow, Inc. | 1.25B | 1.09% | 891,002 | 268.68M |
| 331 | IRMD | IRADIMED CORPORATION | 1.23B | 2.15% | 154,712 | 86.28M |
| 332 | IMTX | Immatics N.V. | 1.23B | -0.65% | 596,079 | 43.00M |
| 333 | INSP | Inspire Medical Systems, Inc. | 1.22B | 0.64% | 604,572 | 915.25M |
| 334 | TNDM | Tandem Diabetes Care, Inc. | 1.21B | -4.66% | 2,637,949 | 1.03B |
| 335 | AVLN | Avalyn Pharma Inc. | 1.20B | 2.17% | 200,671 | - |
| 336 | COAG | Hemab Therapeutics Holdings, Inc. | 1.19B | 5.68% | 182,467 | - |
| 337 | AHG | Akso Health Group | 1.19B | 4.51% | 6,956 | 14.84M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.18B | -2.29% | 946,171 | 3.42B |
| 339 | CDNA | CareDx, Inc. | 1.18B | 3.64% | 754,444 | 412.82M |
| 340 | AVNS | Avanos Medical, Inc. | 1.17B | 0.12% | 702,957 | 715.90M |
| 341 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 4.60% | 334,256 | 10.00M |
| 342 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | 0.91% | 396,886 | 83.72M |
| 343 | PNTG | The Pennant Group, Inc. | 1.14B | 4.43% | 322,383 | 1.02B |
| 344 | XERS | Xeris Biopharma Holdings, Inc. | 1.12B | 4.17% | 1,706,057 | 314.85M |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 3.40% | 258,278 | 796.33M |
| 346 | WVE | Wave Life Sciences Ltd. | 1.11B | 1.40% | 3,802,366 | 71.80M |
| 347 | CNMD | CONMED Corporation | 1.11B | 6.99% | 499,013 | 1.37B |
| 348 | MNKD | MannKind Corporation | 1.10B | 5.31% | 4,907,647 | 360.78M |
| 349 | OMDA | Omada Health, Inc. | 1.09B | 2.46% | 901,389 | 283.30M |
| 350 | OPK | OPKO Health, Inc. | 1.09B | 0.70% | 2,000,941 | 581.12M |
| 351 | SDGR | Schrรถdinger, Inc. | 1.08B | 0.83% | 942,651 | 254.91M |
| 352 | ABSI | Absci Corporation | 1.06B | 4.27% | 4,549,707 | 1.84M |
| 353 | CRON | Cronos Group Inc. | 1.05B | 0.72% | 1,774,954 | 159.54M |
| 354 | AKTS | Aktis Oncology, Inc. | 1.05B | 0.42% | 129,814 | 8.28M |
| 355 | AZTA | Azenta, Inc. | 1.05B | 0.04% | 1,000,355 | 596.48M |
| 356 | INNV | InnovAge Holding Corp. | 1.04B | 4.34% | 565,515 | 949.17M |
| 357 | PSNL | Personalis, Inc. | 1.02B | -2.89% | 4,010,830 | 64.52M |
| 358 | AORT | Artivion, Inc. | 1.01B | 2.40% | 1,118,186 | 458.69M |
| 359 | EYPT | EyePoint, Inc. | 986.81M | 2.79% | 1,874,484 | 7.61M |
| 360 | EVO | Evotec SE | 976.08M | -2.67% | 26,214 | 859.03M |
| 361 | QDEL | QuidelOrtho Corporation | 950.58M | -3.66% | 1,908,165 | 2.66B |
| 362 | USPH | U.S. Physical Therapy, Inc. | 940.52M | 0.82% | 171,152 | 787.69M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 939.29M | 0.18% | 1,624,198 | - |
| 364 | DBVT | DBV Technologies S.A. | 937.35M | 0.19% | 117,904 | 5.74M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 936.47M | 9.01% | 148,386 | - |
| 366 | SPRY | ARS Pharmaceuticals, Inc. | 934.44M | 4.67% | 877,523 | 98.99M |
| 367 | NUTX | Nutex Health Inc. | 931.73M | 0.74% | 110,339 | 879.95M |
| 368 | PCRX | Pacira BioSciences, Inc. | 913.27M | 1.53% | 412,660 | 734.86M |
| 369 | OLMA | Olema Pharmaceuticals, Inc. | 912.78M | 4.92% | 1,008,867 | - |
| 370 | AVR | Anteris Technologies Global Corp. | 911.21M | 1.39% | 1,696,514 | 1.85M |
| 371 | JBIO | Jade Biosciences, Inc. | 903.46M | 1.60% | 1,598,187 | - |
| 372 | GDRX | GoodRx Holdings, Inc. | 897.49M | 0.76% | 1,578,145 | 787.89M |
| 373 | PHAR | Pharming Group N.V. | 894.04M | -1.64% | 4,130 | 369.49M |
| 374 | AMPH | Amphastar Pharmaceuticals, Inc. | 888.91M | 4.05% | 506,256 | 720.53M |
| 375 | XNCR | Xencor, Inc. | 881.54M | 4.21% | 1,009,031 | 97.36M |
| 376 | TALK | Talkspace, Inc. | 872.74M | - | 1,699,203 | 238.37M |
| 377 | INMD | InMode Ltd. | 859.14M | 0.44% | 526,310 | 374.64M |
| 378 | MGTX | MeiraGTx Holdings plc | 852.93M | 1.32% | 593,022 | 79.76M |
| 379 | ANNX | Annexon, Inc. | 851.98M | 1.56% | 3,194,947 | - |
| 380 | TBPH | Theravance Biopharma, Inc. | 850.11M | 1.23% | 332,098 | 109.78M |
| 381 | ABUS | Arbutus Biopharma Corporation | 839.54M | 0.24% | 1,072,407 | 191.45M |
| 382 | LBRX | LB Pharmaceuticals Inc | 839.37M | -0.14% | 362,817 | - |
| 383 | ETON | Eton Pharmaceuticals, Inc. | 836.29M | 1.94% | 219,046 | 86.93M |
| 384 | LXRX | Lexicon Pharmaceuticals, Inc. | 835.09M | - | 1,262,124 | 69.64M |
| 385 | LMRI | Lumexa Imaging Holdings, Inc. | 831.10M | 6.40% | 938,320 | 1.03B |
| 386 | JANX | Janux Therapeutics, Inc. | 830.61M | 1.11% | 507,643 | 13.73M |
| 387 | DRTS | Alpha Tau Medical Ltd. | 828.72M | -0.97% | 767,528 | - |
| 388 | ORIC | ORIC Pharmaceuticals, Inc. | 828.14M | 6.24% | 1,714,725 | - |
| 389 | ODTX | Odyssey Therapeutics, Inc. | 812.81M | 0.64% | 269,275 | 2.98M |
| 390 | CGEM | Cullinan Therapeutics, Inc. | 810.02M | -0.75% | 1,391,282 | - |
| 391 | ESPR | Esperion Therapeutics, Inc. | 808.34M | -0.32% | 7,210,211 | 418.24M |
| 392 | ZVRA | Zevra Therapeutics, Inc. | 807.51M | 12.99% | 5,261,792 | 122.29M |
| 393 | CERT | Certara, Inc. | 805.82M | -0.77% | 4,341,187 | 419.75M |
| 394 | SANA | Sana Biotechnology, Inc. | 784.78M | 4.83% | 8,760,909 | - |
| 395 | KURA | Kura Oncology, Inc. | 782.10M | 2.92% | 2,013,608 | 71.64M |
| 396 | IVA | Inventiva S.A. | 781.60M | 1.53% | 972,916 | 7.94M |
| 397 | PHAT | Phathom Pharmaceuticals, Inc. | 780.00M | -1.80% | 795,994 | 204.89M |
| 398 | BVS | Bioventus Inc. | 768.52M | 2.79% | 488,892 | 576.30M |
| 399 | REPL | Replimune Group, Inc. | 762.97M | 3.01% | 2,621,844 | - |
| 400 | HSTM | HealthStream, Inc. | 759.59M | 1.36% | 193,688 | 311.78M |
| 401 | ANRO | Alto Neuroscience, Inc. | 741.37M | 15.95% | 598,168 | - |
| 402 | EVMN | Evommune, Inc. | 738.02M | 1.49% | 379,027 | 10.00M |
| 403 | OMER | Omeros Corporation | 721.58M | 1.22% | 1,544,595 | 9.89M |
| 404 | VOR | Vor Biopharma Inc. | 719.59M | -0.08% | 867,772 | - |
| 405 | GERN | Geron Corporation | 718.50M | -0.88% | 13,609,087 | 196.12M |
| 406 | SSII | SS Innovations International, Inc. | 711.79M | 0.85% | 69,326 | 48.47M |
| 407 | NNNN | Anbio Biotechnology | 709.28M | -6.16% | 35,504 | 8.65M |
| 408 | BIOA | BioAge Labs, Inc. | 702.35M | 1.87% | 177,821 | 10.32M |
| 409 | CBLL | CeriBell, Inc. | 701.94M | 1.98% | 433,631 | 95.07M |
| 410 | AURA | Aura Biosciences, Inc. | 700.40M | -2.01% | 647,518 | - |
| 411 | SIBN | SI-BONE, Inc. | 688.74M | 3.74% | 328,669 | 206.22M |
| 412 | DRUG | Bright Minds Biosciences Inc. | 683.54M | 3.86% | 365,462 | - |
| 413 | CRMD | CorMedix Inc. | 678.61M | 1.29% | 1,412,758 | 400.05M |
| 414 | AVTX | Avalo Therapeutics, Inc. | 678.10M | 1.26% | 1,296,505 | 59.00K |
| 415 | OCS | Oculis Holding AG | 663.06M | 2.52% | 1,426,036 | 1.40M |
| 416 | DSGN | Design Therapeutics, Inc. | 658.92M | 0.86% | 466,540 | - |
| 417 | RLMD | Relmada Therapeutics, Inc. | 657.66M | 9.62% | 1,685,375 | - |
| 418 | CTMX | CytomX Therapeutics, Inc. | 648.75M | 1.36% | 4,595,834 | 35.54M |
| 419 | SLDB | Solid Biosciences Inc. | 646.81M | 2.50% | 957,614 | - |
| 420 | BBNX | Beta Bionics, Inc. | 641.24M | 3.75% | 885,356 | 110.24M |
| 421 | CSTL | Castle Biosciences, Inc. | 639.36M | 4.77% | 289,481 | 339.92M |
| 422 | CADL | Candel Therapeutics, Inc. | 635.25M | 2.00% | 1,565,387 | - |
| 423 | TENX | Tenax Therapeutics, Inc. | 631.76M | 1.80% | 1,470,837 | - |
| 424 | ALLO | Allogene Therapeutics, Inc. | 628.18M | -1.62% | 7,723,871 | 22.00K |
| 425 | GMRS | GMR Solutions Inc. | 627.62M | 9.83% | 1,162,543 | 5.83B |
| 426 | TLRY | Tilray Brands, Inc. | 616.69M | 2.78% | 4,912,289 | 858.28M |
| 427 | SGP | SpyGlass Pharma, Inc. | 608.03M | -2.93% | 70,064 | - |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 600.55M | -1.38% | 1,022,628 | 8.37M |
| 429 | CBIO | Crescent Biopharma, Inc. | 598.12M | 4.17% | 126,141 | 11.88M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 594.13M | 4.32% | 189,129 | 343.52M |
| 431 | BWAY | BrainsWay Ltd. | 582.31M | 0.14% | 127,621 | 56.22M |
| 432 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 581.58M | -6.68% | 526,212 | - |
| 433 | ACHV | Achieve Life Sciences, Inc. | 574.89M | 2.19% | 1,194,742 | - |
| 434 | PHR | Phreesia, Inc. | 574.23M | -0.54% | 885,402 | 495.59M |
| 435 | RIGL | Rigel Pharmaceuticals, Inc. | 568.38M | 2.13% | 238,791 | 299.77M |
| 436 | GYRE | Gyre Therapeutics, Inc. | 560.11M | 1.32% | 92,636 | 117.05M |
| 437 | IMMX | Immix Biopharma, Inc. | 559.02M | 1.78% | 1,332,718 | - |
| 438 | TRAX | First Tracks Biotherapeutics, Inc. | 557.23M | 1.40% | 391,021 | - |
| 439 | MDXG | MiMedx Group, Inc. | 552.59M | 0.27% | 1,134,621 | 389.42M |
| 440 | NPCE | NeuroPace, Inc. | 544.14M | 2.11% | 96,174 | 99.53M |
| 441 | DNA | Ginkgo Bioworks Holdings, Inc. | 538.93M | 1.98% | 1,102,712 | 151.40M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 538.90M | -1.86% | 258,778 | - |
| 443 | CTKB | Cytek Biosciences, Inc. | 533.36M | 2.23% | 2,024,300 | 204.17M |
| 444 | CLYM | Climb Bio, Inc. | 531.90M | 3.39% | 3,678,580 | - |
| 445 | EVH | Evolent Health, Inc. | 530.91M | 1.29% | 2,958,543 | 1.89B |
| 446 | IRWD | Ironwood Pharmaceuticals, Inc. | 530.06M | -2.13% | 2,029,520 | 361.51M |
| 447 | XOMA | XOMA Royalty Corporation | 526.10M | 0.07% | 94,914 | 48.56M |
| 448 | FLGT | Fulgent Genetics, Inc. | 525.41M | 1.15% | 309,480 | 320.35M |
| 449 | CABA | Cabaletta Bio, Inc. | 525.04M | 0.63% | 4,551,479 | - |
| 450 | PRME | Prime Medicine, Inc. | 520.18M | -2.70% | 2,358,522 | 4.03M |
| 451 | ALT | Altimmune, Inc. | 517.30M | -2.56% | 3,352,661 | 36.00K |
| 452 | CERS | Cerus Corporation | 516.95M | -0.77% | 2,240,879 | 216.56M |
| 453 | ANGO | AngioDynamics, Inc. | 515.19M | 3.60% | 331,607 | 313.73M |
| 454 | PROK | ProKidney Corp. | 504.44M | -2.34% | 465,794 | 889.00K |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 456 | AQST | Aquestive Therapeutics, Inc. | 500.55M | 2.05% | 1,395,306 | 50.27M |
| 457 | VALN | Valneva SE | 499.00M | -0.56% | 14,809 | 180.25M |
| 458 | TOI | The Oncology Institute, Inc. | 495.92M | -2.17% | 1,749,722 | 545.76M |
| 459 | SRTA | Strata Critical Medical, Inc. | 485.41M | -4.43% | 1,482,254 | 228.58M |
| 460 | CTEV | Claritev Corporation | 483.30M | 4.73% | 67,457 | 978.76M |
| 461 | FDMT | 4D Molecular Therapeutics, Inc. | 482.51M | 6.83% | 609,081 | 88.24M |
| 462 | AGMB | AgomAb Therapeutics NV | 476.72M | -6.11% | 132,041 | - |
| 463 | KYTX | Kyverna Therapeutics, Inc. | 475.16M | 1.82% | 729,561 | - |
| 464 | KIDS | OrthoPediatrics Corp. | 474.92M | 1.43% | 105,282 | 243.30M |
| 465 | EIKN | Eikon Therapeutics, Inc. | 474.80M | -2.34% | 204,985 | - |
| 466 | ARVN | Arvinas, Inc. | 465.20M | 0.84% | 981,343 | 89.40M |
| 467 | NGNE | Neurogene Inc. | 455.25M | 0.73% | 549,592 | 925.00K |
| 468 | OVID | Ovid Therapeutics Inc. | 451.67M | 2.54% | 1,483,630 | 7.12M |
| 469 | ASMB | Assembly Biosciences, Inc. | 449.65M | 0.58% | 243,770 | 71.10M |
| 470 | VREX | Varex Imaging Corporation | 448.69M | 3.46% | 275,864 | 857.50M |
| 471 | NRC | NRC Health | 444.65M | 2.07% | 164,552 | 138.64M |
| 472 | WEAV | Weave Communications, Inc. | 443.98M | -1.59% | 776,747 | 248.72M |
| 473 | PRTA | Prothena Corporation plc | 443.43M | -1.05% | 493,462 | 57.94M |
| 474 | EOLS | Evolus, Inc. | 441.23M | 0.30% | 774,649 | 301.79M |
| 475 | ANL | Adlai Nortye Ltd. | 433.60M | 5.96% | 171,094 | 5.00M |
| 476 | CTNM | Contineum Therapeutics, Inc. | 428.82M | -0.52% | 202,905 | - |
| 477 | MYGN | Myriad Genetics, Inc. | 428.79M | 3.42% | 1,138,127 | 829.00M |
| 478 | STRO | Sutro Biopharma, Inc. | 427.35M | 1.50% | 158,760 | 99.61M |
| 479 | PACB | Pacific Biosciences of California, Inc. | 425.52M | -0.72% | 3,834,124 | 160.03M |
| 480 | MOBI | Mobia Medical, Inc. | 420.85M | 0.16% | 113,522 | 32.04M |
| 481 | OCGN | Ocugen, Inc. | 419.77M | -1.59% | 4,580,021 | 4.47M |
| 482 | KMDA | Kamada Ltd. | 418.97M | - | 19,581 | 181.68M |
| 483 | FBRX | Forte Biosciences, Inc. | 415.41M | 8.49% | 415,549 | - |
| 484 | EBS | Emergent BioSolutions Inc. | 410.19M | -0.62% | 818,356 | 676.80M |
| 485 | CCRN | Cross Country Healthcare, Inc. | 408.69M | - | 492,108 | 1.00B |
| 486 | CLPT | ClearPoint Neuro, Inc. | 407.56M | 1.57% | 338,842 | 40.61M |
| 487 | RZLT | Rezolute, Inc. | 407.42M | -4.41% | 2,371,572 | - |
| 488 | EDIT | Editas Medicine, Inc. | 406.67M | 0.19% | 1,877,577 | 38.69M |
| 489 | DCTH | Delcath Systems, Inc. | 403.56M | 6.86% | 1,043,922 | 90.44M |
| 490 | MNPR | Monopar Therapeutics Inc. | 402.66M | -0.82% | 167,459 | - |
| 491 | SGMT | Sagimet Biosciences Inc. | 402.62M | -0.15% | 689,826 | - |
| 492 | OFIX | Orthofix Medical Inc. | 398.96M | 1.86% | 513,404 | 825.37M |
| 493 | IPSC | Century Therapeutics, Inc. | 398.58M | 4.25% | 837,044 | 109.16M |
| 494 | CGC | Canopy Growth Corporation | 395.75M | - | 7,841,667 | 203.04M |
| 495 | CCCC | C4 Therapeutics, Inc. | 394.45M | -0.28% | 1,649,212 | 34.86M |
| 496 | VTVT | vTv Therapeutics Inc. | 394.25M | -0.90% | 12,727 | 36.84M |
| 497 | PRLD | Prelude Therapeutics Incorporated | 390.76M | 2.60% | 235,360 | 16.72M |
| 498 | EPRX | Eupraxia Pharmaceuticals Inc. | 390.48M | -0.33% | 451,972 | - |
| 499 | CYH | Community Health Systems, Inc. | 388.75M | 3.99% | 1,403,853 | 12.29B |
| 500 | AUTL | Autolus Therapeutics plc | 388.57M | - | 1,567,398 | 92.62M |